ETR:HNL - Dr. Hönle Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €63.00
  • Forecasted Upside: 244.26 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€18.30
▼ -1 (-5.18%)

This chart shows the closing price for HNL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Dr. Hönle Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HNL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HNL

Analyst Price Target is €63.00
▲ +244.26% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Dr. Hönle in the last 3 months. The average price target is €63.00, with a high forecast of €0.00 and a low forecast of €0.00. The average price target represents a 244.26% upside from the last price of €18.30.

This chart shows the closing price for HNL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Dr. Hönle. This rating has held steady since May 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/13/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/13/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/12/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/8/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/7/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/14/2021Hauck and AufhaeuserSet Price Target€62.00
10/11/2021Warburg ResearchSet Price Target€64.00
7/21/2021Warburg ResearchSet Price Target€64.00
5/18/2021Warburg ResearchSet Price TargetBuy€63.00
12/9/2020Hauck and AufhaeuserSet Price TargetBuy€68.50
12/3/2020Warburg ResearchSet Price TargetBuy€65.00
12/14/2018Warburg ResearchSet Price TargetBuy€82.00
11/19/2018Warburg ResearchSet Price TargetBuy€82.00
11/13/2018Warburg ResearchSet Price TargetBuy€84.00
(Data available from 7/7/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/9/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/9/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Dr. Hönle

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
Read More

Today's Range

Now: €18.30
Low: €17.86
High: €19.98

50 Day Range

MA: €24.13
Low: €19.30
High: €26.30

52 Week Range

Now: €18.30
Low: €21.40
High: €53.80

Volume

13,967 shs

Average Volume

N/A

Market Capitalization

$110.93 million

P/E Ratio

N/A

Dividend Yield

0.81%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Dr. Hönle?

The following Wall Street sell-side analysts have issued stock ratings on Dr. Hönle in the last year: Hauck and Aufhaeuser, and Warburg Research.
View the latest analyst ratings for HNL.

What is the current price target for Dr. Hönle?

0 Wall Street analysts have set twelve-month price targets for Dr. Hönle in the last year. Their average twelve-month price target is €63.00, suggesting a possible upside of 244.3%.
View the latest price targets for HNL.

What is the current consensus analyst rating for Dr. Hönle?

Dr. Hönle currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HNL.

How do I contact Dr. Hönle's investor relations team?

The company's listed phone number is 49 89 85608 0. The official website for Dr. Hönle is www.hoenle.de. Learn More about contacing Dr. Hönle investor relations.